Lettmann Jason
SEC CIK 1688269 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HOLDINGS INC | Dir, 10% | 294.4K | $149.2K | $13.63M | 12 | 2021-12-08 | 2026-08-17 |
Most active insiders at ALXO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOODMAN COREY S | Dir, 10% | $5.00M | — |
| 2 | Lettmann Jason | CEO, Dir | — | $31.0K |
| 3 | Wong Shelly | SVP, Fin AND CAO | — | $11.6K |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:51 | 2026-08-17 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | S - Sale | $1.93 | -2,230 | 294.4K | -0.8% | -$4,304 | |
| 2026-03-23 | 2026-03-19 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | S - Sale | $2.17 | -12.3K | 293.6K | -4% | -$26.7K | |
| 2026-02-19 | 2026-02-17 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | F - Tax | $2.27 | -2,201 | 305.9K | -0.7% | -$4,996 | |
| M | 2025-09-18 | 2025-09-16+ | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | P - Purchase | $1.08 | +92.2K | 234.0K | +65% | +$99.4K |
| 2025-08-19 | 2025-08-15 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | S - Sale | $0.64 | -2,382 | 212.9K | -1% | -$1,524 | |
| 2025-03-18 | 2025-03-14 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | A - Grant | $0.00 | +42.0K | 212.3K | +25% | $0 | |
| 2025-02-21 | 2025-02-19 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | S - Sale | $1.15 | -2,159 | 170.3K | -1% | -$2,483 | |
| 2024-08-16 | 2024-08-14 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | F - Tax | $2.58 | -2,191 | 169.4K | -1% | -$5,653 | |
| 2024-03-18 | 2024-03-14 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | P - Purchase | $11.31 | +4,400 | 171.6K | +3% | +$49.8K | |
| D | 2024-02-16 | 2024-02-14 | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CEO, Dir | A - Grant | $0.00 | +60.0K | 167.2K | +56% | $0 |
| MI | 2021-12-15 | 2021-12-13 | ALXO | ALX ONCOLOGY HOLDINGS INC | Dir, 10% | S - Sale | $27.36 | -325.4K | 2.10M | -13% | -$8.90M | |
| MI | 2021-12-10 | 2021-12-08+ | ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | Dir, 10% | S - Sale | $32.26 | -145.6K | 2.23M | -6% | -$4.70M |
Purchase Sale Sale after option exercise All abbreviations